Low-dose direct oral anticoagulants tied to more bleeding episodes
Jun 19, 2024
The findings compared with standard doses in patients with atrial fibrillation.
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
Semaglutide cuts risk for kidney outcomes, death in CKD with T2DM
May 31, 2024
A reduction was seen in risk for clinically important kidney outcomes and death from cardiovascular causes.
Semaglutide boosts kidney outcomes with obesity + cardiovascular disease
May 28, 2024
At the prespecified 104-week time point, semaglutide was associated with a lesser decline in eGFR than placebo.
Antihypertensives linked to eczematous dermatitis in seniors
May 24, 2024
The largest effect sizes were seen for diuretics and calcium channel blockers, and the smallest were seen for ACE inhibitors and beta-blockers.
AI may be useful in polypharmacy management
Apr 24, 2024
ChatGPT deprescribing decisions varied along activities of daily living status, cardiovascular disease history, and medication type
Oldest adults with acute myeloid leukemia benefit from Venetoclax
May 16, 2024
Octogenarians and nonagenarians can be treated successfully with VEN-HMA.
One in seven drug supply chain issue reports tied to drug shortages
Apr 10, 2024
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic.
FDA finds no evidence linking Wegovy, Ozempic to suicidal behaviors
Jan 12, 2024
The agency, however, noted that officials cannot rule out that “a small risk may exist,” and said it will continue to investigate.
Eligibility limited for anti-β amyloid mAbs in seniors with MCI
Aug 18, 2023
Few older adults with mild cognitive impairment or mild dementia were eligible for lecanemab or aducanumab after applying clinical trial criteria.